Clinical Trial Update: Study of Intravenous (I.V.) Iclaprim Versus Linezolid in Complicated Skin and Skin Structure Infections [cSSSI] (ASSIST-2) [Phase 3]

View source ↗

Summary

A Phase 3 trial (ASSIST-2) comparing intravenous iclaprim to linezolid for complicated skin and skin structure infections has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complicated Skin and Skin Structure Infections

Drugs mentioned

• Iclaprim (iclaprim)
• Linezolid (Linezolid)

Snippet

Sponsor: Arpida AG | Conditions: Skin Diseases, Bacterial | Phase 3 | Status: COMPLETED